These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Prognostic implications and strategies to avoid ICD shocks]. Horlbeck FW; Nickenig G; Schwab JO Dtsch Med Wochenschr; 2014 Sep; 139(39):1932-6. PubMed ID: 25225862 [No Abstract] [Full Text] [Related]
28. Polymorphic ventricular tachycardia induced by Valsalva manoeuvre in a patient with paroxysmal supraventricular tachycardia. De Mattia L; Brieda M; Del Bianco F; Dametto E; Nicolosi GL Europace; 2012 May; 14(5):767-8. PubMed ID: 22117036 [No Abstract] [Full Text] [Related]
29. The digital pacemaker. Love CJ Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):707-8. PubMed ID: 15189523 [No Abstract] [Full Text] [Related]
30. Catecholaminergic polymorphic ventricular tachycardia (CPVT) initially diagnosed as idiopathic ventricular fibrillation: the importance of thorough diagnostic work-up and follow-up. Siegers CE; Visser M; Loh P; van der Heijden JF; Hassink RJ Int J Cardiol; 2014 Dec; 177(2):e81-3. PubMed ID: 25456695 [No Abstract] [Full Text] [Related]
31. A diagnostic pitfall in a patient with an implantable cardioverter-defibrillator. Burri H; Chevalier P; Touboul P Heart; 2003 Apr; 89(4):470. PubMed ID: 12639887 [No Abstract] [Full Text] [Related]
32. Clinical and genetic profile of catecholaminergic polymorphic ventricular tachycardia in Hong Kong Chinese children. Yu TC; Liu AP; Lun KS; Chung BH; Yung TC Hong Kong Med J; 2016 Aug; 22(4):314-9. PubMed ID: 27256466 [TBL] [Abstract][Full Text] [Related]
33. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B; J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate. Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268 [TBL] [Abstract][Full Text] [Related]
35. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
36. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients. Arenal A; Ortiz M; Peinado R; Merino JL; Quesada A; Atienza F; Alberola AG; Ormaetxe J; Castellanos E; Rodriguez JC; Pérez N; García J; Boluda L; del Prado M; Artés A Heart Rhythm; 2007 Mar; 4(3):316-22. PubMed ID: 17341396 [TBL] [Abstract][Full Text] [Related]
37. Complex diagnosis of catecholaminergic polymorphic ventricular tachycardia. López-Pérez M; Jiménez-Jáimez J; Gil Jiménez T; Macías-Ruiz R; Álvarez-López M; Tercedor-Sánchez L Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):229-31. PubMed ID: 24774404 [No Abstract] [Full Text] [Related]